Zymeworks
ZYME
113 hedge funds and large institutions have $223M invested in Zymeworks in 2022 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 37 increasing their positions, 27 reducing their positions, and 33 closing their positions.
59% more call options, than puts
Call options by funds: $1.51M | Put options by funds: $951K
37% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 27
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3.99% less ownership
Funds ownership: 86.54% → 82.55% (-4%)
6% less funds holding
Funds holding: 120 → 113 (-7)
18% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 33
32% less capital invested
Capital invested by funds: $327M → $223M (-$105M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RG
Redmile Group
San Francisco,
California
|
+$10.4M |
| 2 |
QOP
Quinn Opportunity Partners
Charlottesville,
Virginia
|
+$9.61M |
| 3 |
CAC
Cowen and Company
New York
|
+$9.07M |
| 4 |
Goldman Sachs
New York
|
+$3.99M |
| 5 |
TIM
Timelo Investment Management
Aurora,
Ontario, Canada
|
+$2.95M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$7.76M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$7.7M |
| 3 |
PA
Perceptive Advisors
New York
|
-$7.22M |
| 4 |
Two Sigma Investments
New York
|
-$5.18M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$5.01M |
ZYME Hedge Fund Activity: Q2 2022 in Review
113 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Zymeworks (ZYME) for Q2 2022, worth a combined $223M — down 32% from $327M a quarter earlier.
Sellers outnumbered buyers: 33 funds closed out of ZYME and 27 opened new positions — a net loss of 6 holders — while 27 trimmed existing stakes and 37 added.
The largest buyer was Redmile Group, adding an estimated $10.4M. The largest seller was Millennium Management, exiting entirely with an estimated $7.76M sold.
- 113 institutional investors held Zymeworks (ZYME) as of Q2 2022, down from 120 in Q1 2022.
- Funds reported $223M of Zymeworks stock for Q2 2022, down 32% quarter-over-quarter.
- 27 funds opened new Zymeworks positions in Q2 2022 and 33 closed out, a net change of -6 holders.
- The largest Zymeworks buyer in Q2 2022 was Redmile Group, an estimated $10.4M added.
- The largest Zymeworks seller in Q2 2022 was Millennium Management, an estimated $7.76M sold.
Based on aggregated 13F filings for Q2 2022.